The biopharmaceutical company is the maker of Thalomid and various other drugs that treat multimple myeloma, inflammatory diseases, and various forms of cancer.
Looking for leads, investment insights, or competitive intelligence?
News about Celgene
Celgene boosted the price of a 10-milligram dose of Revlimid by 3.5% to $719.82 effective Jan. 3.
Must-read business news, delivered every morning.
It's one of the largest pharmaceutical-company mergers ever.
Russian drugmaker Nativa got a compulsory license to produce a cheaper version of Celgene's Revlimid.